MK2206 (5 μm) effectively inhibited the phosphorylation of AKT (Fig. 4A) and caused mesenchymal HCC cells induced by IL‐17A to revert to an epithelial phenotype (Fig. S4A). Here, IL17A is linked to hepatocellular carcinoma.